Is Europe Moving Away From Cannabis Flower? – Why Companies Are Betting on CE-Certified Devices

Is Europe really moving away from medical cannabis flower, and what does that mean for the future of the industry?

In the latest Business of Cannabis article, emerging European regulatory trends show new markets like Spain and France favouring CE-certified medical devices and alternative formats over traditional dried flower. 🇪🇺🌿

Our CEO, Benjamin Jeanroy, offers an insightful perspective on this shift: France has struck a creative compromise by allowing dried flower in sealed vaporisation capsules compatible with CE-certified devices, addressing regulatory concerns while still preserving patient access; a nuanced alternative to Spain’s outright exclusion of flower.

Benjamin Jeanroy argues that this approach, although not ideal, helps overcome the stigma around flower and could make France a model for future European frameworks, with standardised devices helping integrate cannabis into mainstream medical systems.

👉 Read the full article on Business Of Cannabis to dive deeper into how CE certification, clinical needs, and regulatory trends are reshaping Europe’s medical cannabis landscape.